Sure, 20 to 80 volunteers in a Phase 1 Study, which is designed to prove safety, not efficacy.
But that's moot because Ilfeld's study is a PILOT Study, not a study designed to clinically prove anything. It doesn't have ENDPOINTS, it has AIMS, and they are: